| scholarly article | Q13442814 |
| P50 | author | Nils Ludwig | Q87673127 |
| P2093 | author name string | Theresa L Whiteside | |
| P2860 | cites work | Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes | Q24604279 |
| Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
| Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development | Q28397739 | ||
| Retracted: Carboxyamidotriazole-Orotate Inhibits the Growth of Imatinib-Resistant Chronic Myeloid Leukaemia Cells and Modulates Exosomes-Stimulated Angiogenesis | Q28482070 | ||
| Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation | Q28567998 | ||
| CD44v6 dependence of premetastatic niche preparation by exosomes | Q28568064 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| Angiogenesis in health and disease | Q29614541 | ||
| Hypoxic enhancement of exosome release by breast cancer cells. | Q30527905 | ||
| Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion | Q30537455 | ||
| Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells | Q30908848 | ||
| Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis | Q33641799 | ||
| Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. | Q34683987 | ||
| Egr-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1/2 and JNK signaling pathways | Q34690943 | ||
| Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis | Q35608487 | ||
| Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression | Q39023529 | ||
| Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. | Q39033034 | ||
| Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells | Q39077569 | ||
| Exosomes and their role in the micro-/macro-environment: a comprehensive review | Q39177208 | ||
| Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells | Q39186608 | ||
| Leukemia cell to endothelial cell communication via exosomal miRNAs. | Q39314508 | ||
| New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes | Q39691353 | ||
| Cellular internalization of exosomes occurs through phagocytosis | Q39742924 | ||
| STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells | Q41158024 | ||
| Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis | Q41233236 | ||
| Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma | Q41686929 | ||
| Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts | Q42367399 | ||
| Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2. | Q42835218 | ||
| Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells | Q42855929 | ||
| Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles | Q47250358 | ||
| The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy | Q47337961 | ||
| Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. | Q47911670 | ||
| Hypoxia Inducible Factor-1α Potentiates Jagged 1-Mediated Angiogenesis by Mesenchymal Stem Cell-Derived Exosomes | Q48321458 | ||
| Extracellular vesicle-mediated transfer of constitutively active MyD88L265P engages MyD88wt and activates signaling. | Q49875982 | ||
| Exosomes as a liquid biopsy for lung cancer. | Q50139945 | ||
| Exosomes Derived From Hypoxic Colorectal Cancer Cells Promote Angiogenesis Through Wnt4-Induced β-Catenin Signaling in Endothelial Cells. | Q51422684 | ||
| Proteomic analysis of microvesicles derived from human colorectal cancer ascites. | Q52611911 | ||
| Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. | Q53286756 | ||
| Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma. | Q55030529 | ||
| The tumor microenvironment at a glance. | Q55057036 | ||
| Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis | Q57983943 | ||
| Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche | Q58831489 | ||
| Angiogenesis: initiation and control. | Q64888209 | ||
| Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029 | Q79929804 | ||
| Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo | Q82357101 | ||
| Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). | Q35856812 | ||
| Paracrine induction of endothelium by tumor exosomes. | Q35862798 | ||
| Optimized exosome isolation protocol for cell culture supernatant and human plasma | Q35867005 | ||
| CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. | Q35954464 | ||
| The genomic and proteomic content of cancer cell-derived exosomes | Q35971555 | ||
| Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation | Q36098121 | ||
| Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis | Q36467398 | ||
| Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells | Q36503188 | ||
| Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets | Q36542190 | ||
| Exosomes and tumor-mediated immune suppression | Q36737920 | ||
| Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes | Q36742116 | ||
| Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche | Q36782329 | ||
| The tumor microenvironment and its role in promoting tumor growth | Q36946019 | ||
| Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma | Q37022210 | ||
| Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells | Q37190155 | ||
| Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo. | Q37240065 | ||
| Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21. | Q37327507 | ||
| Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells | Q37706076 | ||
| Exosomes in tumor microenvironment influence cancer progression and metastasis | Q38091978 | ||
| Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions | Q38306666 | ||
| Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3. | Q38710814 | ||
| From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis. | Q38736928 | ||
| Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis | Q38739625 | ||
| Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression | Q38787818 | ||
| Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake | Q38800211 | ||
| Tumor-Derived Exosomes and Their Role in Cancer Progression | Q38818439 | ||
| Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells | Q38855159 | ||
| Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins. | Q38889253 | ||
| Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer | Q38889667 | ||
| Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. | Q38952592 | ||
| Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors | Q38974186 | ||
| WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells | Q39001226 | ||
| miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. | Q39018734 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 409-417 | |
| P577 | publication date | 2018-04-26 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Potential roles of tumor-derived exosomes in angiogenesis | |
| P478 | volume | 22 |
| Q60961340 | A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis |
| Q91645137 | A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy |
| Q60919625 | Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System |
| Q96945870 | Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy |
| Q100736946 | Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression |
| Q64100292 | Exosome-orchestrated hypoxic tumor microenvironment |
| Q93054875 | Exosomes in the Regulation of Vascular Endothelial Cell Regeneration |
| Q92542954 | Extracellular Vesicles From Pathological Microenvironment Induce Endothelial Cell Transformation and Abnormal Angiogenesis via Modulation of TRPV4 Channels |
| Q92486982 | Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis |
| Q64244729 | Recent Progress on Liquid Biopsy Analysis using Surface-Enhanced Raman Spectroscopy |
| Q91828311 | Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy |
| Q96111705 | Role of exosome-associated adenosine in promoting angiogenesis |
| Q90209251 | TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway |
| Q89511180 | Tspan8-Tumor Extracellular Vesicle-Induced Endothelial Cell and Fibroblast Remodeling Relies on the Target Cell-Selective Response |
| Q99552012 | Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy |
| Q91797808 | Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer |
Search more.